BSE:524816 1 December 2025

Natco Pharma Share Price Today (1 December 2025): Q2 Results, USFDA Update, Adcock Ingram Deal & 2026 Forecast

Natco Pharma shares jumped nearly 5% to around ₹921 on the NSE by 11:05 am IST Friday, with volumes nearing 2.95 million. The rally follows Q2 FY26 results showing flat revenue at ₹1,363 crore and a 23% drop in net profit to ₹517.9 crore, as Revlimid profits fade and costs rise. Management expects little Revlimid contribution from Q3 onward but has kept full-year PAT guidance at ₹13 billion.

1 December 2025

BSE:524816·NSE:NATCOPHARM·Stock Market

Xanadu Quantum Technologies to List on Nasdaq and TSX After Shareholder Approval
March 20, 2026, 12:11 AM EDT. Xanadu Quantum Technologies is set to become the first publicly listed photonic quantum technology company. Following shareholder approval of the merger with Crane Harbor Acquisition Corp. (Nasdaq: CHAC), the new entity, Xanadu Quantum Technologies Limited, will begin trading on Nasdaq and the Toronto Stock Exchange under ticker "XNDU" on March 27, 2026. The merger will provide approximately $302 million in gross proceeds to support Xanadu's development of light-based quantum computing technology, which operates at room temperature and avoids costly cooling systems. This capital complements a potential CAD 390 million investment from Canadian and Ontario governments, backing the company's efforts to scale its hardware, software, and cloud-based quantum platforms.